Nanoscope Therapeutics: Optogenetic Therapies For Retinal Degenerative Disease – Clinical Developments And Updates
Location: 118/119
Date & Time: Friday, 20 September, 09:45 - 10:45 CEST
Chairperson(s): J. Monés, SPAIN, F. Bandello, ITALY (Co-Chair)
Speakers:
Presentations:
J. Monés SPAIN
09:45 Opening Remarks
A. Khanani USA
09:48 Degenerative Retinal Diseases
P. Stanga UK
09:58 Optogenetic Therapies for IRDs
J. Monés SPAIN
10:08 Optogenetic Therapies for Macular Degeneration
U. Chakravarthy UK
10:18 Imaging and Efficacy Evaluations in Assessing Low-Vision Patients Treated with Optogenetics
All Speakers
10:28 Q&A
This is a promotional symposium for HCPs only. Presentations and materials disclosed during the event are subject to Intellectual Property Rights. Total or partial reproduction or use of this content requires prior AbbVie authorization. Furthermore, in order to comply with the regulations regarding the promotion of medicines, we ask you not to share its contents on your social networks. Please do not distribute in media, or communication channels aimed at the general public.